ImmunityBio (IBRX) Receivables (2014 - 2026)
ImmunityBio (IBRX) recorded Receivables of $53.5 million in Q2 2026, up 139.6% from $22.33 million a year earlier and up 23.6% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Receivables (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio reported Receivables of $42.62 million.
- Annual Receivables has a three-year compound annual growth rate of 137.3% (FY2022 to FY2025).
- Across earlier years, Receivables came in at $2.65 million in FY2024 (+31.4%), $2.02 million in FY2023 (-36.7%) and $3.19 million in FY2022.
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q4 2014.
- Peak year-over-year performance for Receivables in the last five years was growth of 984.0% in Q2 2025, against a decline of 38.0% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $43.27 million (Q1 2026), $42.62 million (Q4 2025) and $33.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 53.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.50 Mn |
| Mar 31, 2026 | 43.27 Mn |
| Dec 31, 2025 | 42.62 Mn |
| Sep 30, 2025 | 33.70 Mn |
| Jun 30, 2025 | 22.33 Mn |
| Mar 31, 2025 | 17.45 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 2.06 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Jun 30, 2016 | 124,000.00 |
| Jun 30, 2015 | 45,000.00 |
| Dec 31, 2014 | 145,000.00 |
API Access
ImmunityBio Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();